RU99106170A - METHOD FOR PREVENTION AND TREATMENT OF HYPERENDOTOXINEMIA - Google Patents

METHOD FOR PREVENTION AND TREATMENT OF HYPERENDOTOXINEMIA

Info

Publication number
RU99106170A
RU99106170A RU99106170/14A RU99106170A RU99106170A RU 99106170 A RU99106170 A RU 99106170A RU 99106170/14 A RU99106170/14 A RU 99106170/14A RU 99106170 A RU99106170 A RU 99106170A RU 99106170 A RU99106170 A RU 99106170A
Authority
RU
Russia
Prior art keywords
hyperendotoxinemia
prevention
treatment
hepatoprotectors
sorbents
Prior art date
Application number
RU99106170/14A
Other languages
Russian (ru)
Other versions
RU2177319C2 (en
Inventor
Юрий Владимирович Конев
Михаил Юрьевич Яковлев
Ирина Альфредовна Аниховская
Original Assignee
Российская медицинская академия последипломного образования Министерства здравоохранения Российской Федерации
Filing date
Publication date
Application filed by Российская медицинская академия последипломного образования Министерства здравоохранения Российской Федерации filed Critical Российская медицинская академия последипломного образования Министерства здравоохранения Российской Федерации
Priority to RU99106170A priority Critical patent/RU2177319C2/en
Priority claimed from RU99106170A external-priority patent/RU2177319C2/en
Publication of RU99106170A publication Critical patent/RU99106170A/en
Application granted granted Critical
Publication of RU2177319C2 publication Critical patent/RU2177319C2/en

Links

Claims (4)

1. Способ профилактики и лечения гиперэндотоксинемии, включающий введение в организм лекарственных препаратов, отличающийся тем, что в качестве лекарственных препаратов вводят пробиотики, гепатопротекторы и сорбенты.1. A method for the prevention and treatment of hyperendotoxinemia, including the introduction of drugs into the body, characterized in that probiotics, hepatoprotectors and sorbents are administered as drugs. 2. Способ по п.1, отличающийся тем, что в качестве пробиотиков используют препараты, содержащие бифидобактерии и/или лактобактерии и/или продукты их жизнедеятельности. 2. The method according to claim 1, characterized in that as probiotics use preparations containing bifidobacteria and / or lactobacilli and / or their metabolic products. 3. Способ по п.1, отличающийся тем, что в качестве гепатопротекторов используют эссенцеале-форте и/или хофитол и/или гептрал. 3. The method according to claim 1, characterized in that as hepatoprotectors use essenteale-forte and / or hofitol and / or heptral. 4. Способ по п.1, отличающийся тем, что в качестве сорбентов используют активированный уголь и/или полифепам. 4. The method according to claim 1, characterized in that activated carbon and / or polypepam are used as sorbents.
RU99106170A 1999-03-30 1999-03-30 Method of treatment of hyperendotoxinemia RU2177319C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU99106170A RU2177319C2 (en) 1999-03-30 1999-03-30 Method of treatment of hyperendotoxinemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU99106170A RU2177319C2 (en) 1999-03-30 1999-03-30 Method of treatment of hyperendotoxinemia

Publications (2)

Publication Number Publication Date
RU99106170A true RU99106170A (en) 2001-01-10
RU2177319C2 RU2177319C2 (en) 2001-12-27

Family

ID=20217705

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99106170A RU2177319C2 (en) 1999-03-30 1999-03-30 Method of treatment of hyperendotoxinemia

Country Status (1)

Country Link
RU (1) RU2177319C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201204696D0 (en) * 2012-03-16 2012-05-02 Ucl Business Plc Therapy

Similar Documents

Publication Publication Date Title
TW250435B (en)
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
HUP0204085A3 (en) New oxabispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them
HUP0204574A3 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity, pharmaceutical compositions containing them and their preparation
SI0825178T1 (en) Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them
CA2387873A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
CA2150184A1 (en) Pharmaceutical composition for the treatment of inflammatory bowel diseases
PL332643A1 (en) 1h-pyrido-[3,4-b]-indolo-4-carboxyamidic derivatives, their production and application in medical treatment
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
CA2290482A1 (en) Fructan containing composition for the prevention and treatment of colon cancer
CZ20021489A3 (en) N-guanidinoalkylamides, process of their preparation, use and pharmaceutical mixtures in which they are comprised
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
IL148128A0 (en) Spherical agglomerates of telithromycin, their preparation process and their use in the preparation of pharmaceutical forms
RU99106170A (en) METHOD FOR PREVENTION AND TREATMENT OF HYPERENDOTOXINEMIA
UA39179C2 (en) Pharmaceutical composition for treating disorders of heart rhythm in large mammalians and humans, method for its preparation and antiarrhythmic drug
HUP0200439A2 (en) Isonipecotamides for the treatment of integrin-mediated disorders, process for their preparation and pharmaceutical compositions containing them
AU3255295A (en) Hybrid molecules useful in the treatment of tumors, their preparation and use in pharmaceutical compositions
HUP0203959A3 (en) New bispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them
EP0897988A4 (en) Physiologically active substances tkr1785's, process for the preparation thereof, and microbe
AU8855598A (en) Pharmaceutical products containing triiodoaromats containing perfluoroalkyl groups, and the use thereof in the treatment of tumours and interventional radiology
HUP0202929A3 (en) New bispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them
GR920100469A (en) Pharmaceutical substances.
EP0622363A3 (en) 2-amino-5-cyano-4-quinolyldihydropyridine esters, process for their preparation and their use in medicine for the treatment of heart-circulatory illnesses.
RU96113663A (en) CORONAROGRAPHY METHOD IN EXPERIMENT